PORTEFEUILLE

Chronic inflammation is one of the largest unsolved healthcare issues of our society. Lifestyle adjustments such as optimized diets or increased physical activity are effective to fight chronic inflammations. However, every individual requires a different set of personalized adjustments. Unfortunately, there is currently no way to tailor the optimal anti-inflammatory measures to the personal needs of chronically inflamed individuals.
Hemetron develops a uniquely accurate and quantitative blood test for inflammation self-monitoring. Our solution empowers users to determine how to effectively decrease their inflammation.

During our GRS InnoBooster project, we improved our hand-held blood test prototype. It is important to bring a device to the market that provides optimal performance while also being easy to use. The project enables us to tailor our solution to the customers’ needs and accelerate our market entry.